William Garvin, Shareholder in the firm's FDA & Biotechnology section, delivered a regulatory update at Specialty Pharma Association's 2018 Annual Pharma Conference.
We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.
Already a subscriber and want to update your preferences? Click here.